LUMO Study
Cross-source consensus on LUMO Study from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Comparisons
Background
Highlighted claims
- The LUMO study is a study protocol investigating whether luteal phase support in MOH-IUI treatment improves cumulative live birth rates. — Correction: Does luteal phase support in MOH-IUI treatment improve cumulative live birth rates in couples with unexplained subfertility? Study protocol of the LUMO study: a multicentre, randomised, double-blind, controlled trial with cost-effectiveness analysis
- The LUMO study is designed as a multicentre, randomised, double-blind, controlled trial. — Correction: Does luteal phase support in MOH-IUI treatment improve cumulative live birth rates in couples with unexplained subfertility? Study protocol of the LUMO study: a multicentre, randomised, double-blind, controlled trial with cost-effectiveness analysis
- The LUMO study was published in BMJ Open volume 15, with identifier e111872 and DOI 10.1136/bmjopen-2025-111872. — Correction: Does luteal phase support in MOH-IUI treatment improve cumulative live birth rates in couples with unexplained subfertility? Study protocol of the LUMO study: a multicentre, randomised, double-blind, controlled trial with cost-effectiveness analysis
- The named authorship of the LUMO study begins with Emma Preesman, Katja Drechsel, and Heleen Crommelin, with many additional collaborators. — Correction: Does luteal phase support in MOH-IUI treatment improve cumulative live birth rates in couples with unexplained subfertility? Study protocol of the LUMO study: a multicentre, randomised, double-blind, controlled trial with cost-effectiveness analysis
- The LUMO study includes cost-effectiveness analysis as part of its study design, going beyond clinical outcomes to evaluate economic value. — Correction: Does luteal phase support in MOH-IUI treatment improve cumulative live birth rates in couples with unexplained subfertility? Study protocol of the LUMO study: a multicentre, randomised, double-blind, controlled trial with cost-effectiveness analysis